HomeComparePKI vs AME

PKI vs AME: Dividend Comparison 2026

PKI yields 0.24% · AME yields 0.61%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AME wins by $73.0K in total portfolio value
10 years
PKI
PKI
● Live price
0.24%
Share price
$115.24
Annual div
$0.28
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.02
Full PKI calculator →
AME
AME
● Live price
0.61%
Share price
$208.37
Annual div
$1.27
5Y div CAGR
72.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$92.7K
Annual income
$38,389.01
Full AME calculator →

Portfolio growth — PKI vs AME

📍 AME pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKIAME
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKI + AME cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKI pays
AME pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKI
Annual income on $10K today (after 15% tax)
$20.65/yr
After 10yr DRIP, annual income (after tax)
$0.02/yr
AME
Annual income on $10K today (after 15% tax)
$51.81/yr
After 10yr DRIP, annual income (after tax)
$32,630.66/yr
At 15% tax rate, AME beats the other by $32,630.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKI + AME for your $10,000?

PKI: 50%AME: 50%
100% AME50/50100% PKI
Portfolio after 10yr
$56.2K
Annual income
$19,194.52/yr
Blended yield
34.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on AME right now

PKI
Analyst Ratings
13
Buy
18
Hold
Consensus: Hold
Price Target
$166.57
+44.5% upside vs current
Range: $145.00 — $202.00
Altman Z
2.9
Piotroski
7/9
AME
Analyst Ratings
20
Buy
9
Hold
Consensus: Buy
Price Target
$241.64
+16.0% upside vs current
Range: $215.00 — $271.00
Altman Z
6.1
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKI buys
0
AME buys
0
No recent congressional trades found for PKI or AME in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKIAME
Forward yield0.24%0.61%
Annual dividend / share$0.28$1.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%72.1%
Portfolio after 10y$19.7K$92.7K
Annual income after 10y$0.02$38,389.01
Total dividends collected$24.00$68.5K
Payment frequencyquarterlyquarterly
SectorStockIndustrials
Analyst consensusHoldBuy
Analyst price target$166.57$241.64

Year-by-year: PKI vs AME ($10,000, DRIP)

YearPKI PortfolioPKI Income/yrAME PortfolioAME Income/yrGap
1← crossover$10,712$12.15$10,805$104.89$93.00AME
2$11,468$6.08$11,744$182.29$276.00AME
3$12,274$3.04$12,884$318.67$610.00AME
4$13,135$1.52$14,348$562.34$1.2KAME
5$14,055$0.76$16,360$1,007.27$2.3KAME
6$15,039$0.38$19,353$1,847.23$4.3KAME
7$16,092$0.19$24,222$3,514.56$8.1KAME
8$17,218$0.10$32,993$7,075.16$15.8KAME
9$18,424$0.05$50,802$15,500.35$32.4KAME
10$19,713$0.02$92,748$38,389.01$73.0KAME

PKI vs AME: Complete Analysis 2026

PKIStock

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Full PKI Calculator →

AMEIndustrials

AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets. This segment also provides power quality monitoring and metering devices, uninterruptible power supplies, programmable power equipment, electromagnetic compatibility test equipment, gas turbines, and environmental health and safety market sensors, dashboard instruments for heavy trucks and other vehicles, and instrumentation and controls for the food and beverage industries; and aircraft and engine sensors, monitoring systems, power supplies, fuel and fluid measurement systems, and data acquisition systems for the aerospace industry. Its EMG segment offers engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, automation, and other applications; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for use in thermal management, military, commercial aircraft, and military ground vehicles; and motors for use in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, and industrial blowers. This segment also operates a network of aviation maintenance, repair, and overhaul facilities. In addition, the company offers clinical and educational communication solutions. AMETEK, Inc. was founded in 1930 and is headquartered in Berwyn, Pennsylvania.

Full AME Calculator →
📬

Get this PKI vs AME comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKI vs SCHDPKI vs JEPIPKI vs OPKI vs KOPKI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.